These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9253202)
1. Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl-phthalocyanine. Fabris C; Ometto C; Milanesi C; Jori G; Cook MJ; Russell DA J Photochem Photobiol B; 1997 Jul; 39(3):279-84. PubMed ID: 9253202 [TBL] [Abstract][Full Text] [Related]
2. Relative contributions of apoptosis and random necrosis in tumour response to photodynamic therapy: effect of the chemical structure of Zn(II)-phthalocyanines. Jori G; Fabris C J Photochem Photobiol B; 1998 Jun; 43(3):181-5. PubMed ID: 9718718 [TBL] [Abstract][Full Text] [Related]
3. Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines. Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA Br J Cancer; 1995 Apr; 71(4):727-32. PubMed ID: 7710936 [TBL] [Abstract][Full Text] [Related]
4. Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine. Ometto C; Fabris C; Milanesi C; Jori G; Cook MJ; Russell DA Br J Cancer; 1996 Dec; 74(12):1891-9. PubMed ID: 8980387 [TBL] [Abstract][Full Text] [Related]
5. CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours. Segalla A; Milanesi C; Jori G; Capraro HG; Isele U; Schieweck K Br J Cancer; 1994 May; 69(5):817-25. PubMed ID: 8180009 [TBL] [Abstract][Full Text] [Related]
6. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer. Boyle RW; Rousseau J; Kudrevich SV; Obochi M; van Lier JE Br J Cancer; 1996 Jan; 73(1):49-53. PubMed ID: 8554982 [TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetic and photodynamic studies with zinc(II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma. Shopova M; Mantareva V; Krastev K; Hadjiolov D; Milev A; Spirov K; Jori G; Ricchelli F J Photochem Photobiol B; 1992 Oct; 16(1):83-9. PubMed ID: 1469513 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and phototherapeutic properties of axially substituted Si(IV)-tetradibenzobarreleno-octabutoxyphthalocyanines. Soncin M; Busetti A; Reddi E; Jori G; Rither BD; Kenney ME; Rodgers MA J Photochem Photobiol B; 1997 Sep; 40(2):163-7. PubMed ID: 9345784 [TBL] [Abstract][Full Text] [Related]
9. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Reddi E; Zhou C; Biolo R; Menegaldo E; Jori G Br J Cancer; 1990 Mar; 61(3):407-11. PubMed ID: 2328207 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic activities and biodistribution of fluorinated zinc phthalocyanine derivatives in the murine EMT-6 tumour model. Allémann E; Brasseur N; Kudrevich SV; La Madeleine C; van Lier JE Int J Cancer; 1997 Jul; 72(2):289-94. PubMed ID: 9219835 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles. Allémann E; Rousseau J; Brasseur N; Kudrevich SV; Lewis K; van Lier JE Int J Cancer; 1996 Jun; 66(6):821-4. PubMed ID: 8647656 [TBL] [Abstract][Full Text] [Related]
13. Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice. Brasseur N; Ouellet R; La Madeleine C; van Lier JE Br J Cancer; 1999 Jul; 80(10):1533-41. PubMed ID: 10408394 [TBL] [Abstract][Full Text] [Related]
14. PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. Allémann E; Brasseur N; Benrezzak O; Rousseau J; Kudrevich SV; Boyle RW; Leroux JC; Gurny R; Van Lier JE J Pharm Pharmacol; 1995 May; 47(5):382-7. PubMed ID: 7494187 [TBL] [Abstract][Full Text] [Related]
15. The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. Camerin M; Magaraggia M; Soncin M; Jori G; Moreno M; Chambrier I; Cook MJ; Russell DA Eur J Cancer; 2010 Jul; 46(10):1910-8. PubMed ID: 20356732 [TBL] [Abstract][Full Text] [Related]
16. Effects of photodynamic therapy on the absorption properties of disulphonated aluminum phthalocyanine in tumor-bearing mice. Cubeddu R; Canti G; D'Andrea C; Pifferi A; Taroni P; Torricelli A; Valentini G J Photochem Photobiol B; 2001 Jul; 60(2-3):73-8. PubMed ID: 11470561 [TBL] [Abstract][Full Text] [Related]
17. In vivo absorption spectrum of disulphonated aluminium phthalocyanine in a murine tumour model. Cubeddu R; Canti G; Musolino M; Pifferi A; Taroni P; Valentini G J Photochem Photobiol B; 1996 Jul; 34(2-3):229-35. PubMed ID: 8810541 [TBL] [Abstract][Full Text] [Related]
18. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Canti G; Lattuada D; Nicolin A; Taroni P; Valentini G; Cubeddu R Anticancer Drugs; 1994 Aug; 5(4):443-7. PubMed ID: 7949249 [TBL] [Abstract][Full Text] [Related]
19. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors. Chan WS; Marshall JF; Lam GY; Hart IR Cancer Res; 1988 Jun; 48(11):3040-4. PubMed ID: 3284641 [TBL] [Abstract][Full Text] [Related]
20. Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis. Milanesi C; Zhou C; Biolo R; Jori G Br J Cancer; 1990 Jun; 61(6):846-50. PubMed ID: 2372486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]